Beyond the Genome 2010
Beyond the Genome: The true gene count, human evolution and disease genomics
Joseph B. Martin Conference Center,
Harvard Medical School, Boston, Massachusetts
11th – 13th October 2010
This international conference brings together leading researchers and industry representatives who will review recent progress in key areas of post-genomic research in biology and medicine and chart future developments, including the Human Microbiome Project and the resequencing of matched tumour and normal genomes from specific types of cancers. A cloud computing workshop, which will be open to all delegates, will provide an exciting opportunity to discuss recent and forthcoming developments in this critical and fast-moving field with policy makers and commercial and academic representatives of the genomics community and cloud platforms.
All abstracts presented at the conference can now be viewed at the Genome Biology website.
Why Beyond the Genome?
- Internationally renowned scientific organizing committee and invited speakers.
- Workshop on cloud computing in genomics and bioinformatics, open to all delegates.
- All participants are invited to submit abstracts for oral and poster presentations. A significant number of talks will be selected from registrants.
- Technology showcase: presentations of cutting-edge research informed by state-of-the-art technologies.
- Highly topical scientific program: from basic research to translational genomic medicine, including cancer resequencing and the human microbiome projects.
- A free one year personal subscription to Genome Biologyand its new sister publication Genome Medicine.
- This event is a must-attend for all: Postdoctoral research fellows; Graduate students; Principal investigators in academia and industry; Clinical researchers working in medical genomics.
- Sequencing cancer genomes
- How much of the Genome is functional
- Microbiomes in human and other environments
- Insights from genomic analyses into evolution
- Cloud computing in genomics and bioinformatics (workshop)
At this inaugural Genome Biology conference, which marks the journal’s 10thanniversary and the recent launch of its sister journal Genome Medicine, leading researchers and industry representatives from around the globe will gather to review progress in key areas of post-genomic research in biology and medicine and to chart future developments, including the Human Microbiome Project and the resequencing of matched tumour and normal genomes from specific types of cancers.
The past ten years have brought rapid progress to the field of genomic research, which is beginning to have a great impact on our understanding of functional and regulatory genomics, human health and disease.
Almost a decade after the release of the first draft of the human genome sequence, determining the true number of human genes continues to be contentious. Advances in powerful sequencing and assembly technologies have enabled a clearer view of the actual human gene count.
Identifying the actual gene number in other genomes also continues to be a challenge. We are not simply the sum of our genes: amongst other factors, complex regulatory roles of small RNAs and other non-protein-coding genes, as well as the contribution of microbial genomes shape our development and the specific interplay of these factors continues to be much under debate.
Rapid recent technological advances have also provided new insights into human evolution, and by enabling the resequencing of matched tumour and normal genomes these advances are bringing us closer to a personalized medical approach.
Session 1: Sequencing cancer genomes
Session 2: The number of genes in a genome
Session 3: Microbiomes in human and other environments
Session 4: Insights from genomic analyses into evolution
Researchers, clinicians, graduate students, post doctoral fellows and biotechnological policy makers. Cutting-edge presentations will be delivered by internationally renowned researchers. Short oral platform presentations and posters will be selected from registrants.
BioMed Central is an STM (Science, Technology and Medicine) publisher that has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.